These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 23651481

  • 1. p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.
    Gangwal RP, Bhadauriya A, Damre MV, Dhoke GV, Sangamwar AT.
    Curr Top Med Chem; 2013; 13(9):1015-35. PubMed ID: 23651481
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Virtual screening based on pharmacophore model followed by docking simulation studies in search of potential inhibitors for p38 map kinase.
    Shahlaei M, Doosti E.
    Biomed Pharmacother; 2016 May; 80():352-372. PubMed ID: 27133076
    [Abstract] [Full Text] [Related]

  • 4. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors.
    Park H, Lee S, Hong S.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3784-7. PubMed ID: 26259807
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening.
    Gangwal RP, Das NR, Thanki K, Damre MV, Dhoke GV, Sharma SS, Jain S, Sangamwar AT.
    J Mol Graph Model; 2014 Apr 15; 49():18-24. PubMed ID: 24473068
    [Abstract] [Full Text] [Related]

  • 7. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
    Xiao Z, Varma S, Xiao YD, Tropsha A.
    J Mol Graph Model; 2004 Oct 15; 23(2):129-38. PubMed ID: 15363455
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors.
    Heo J, Shin H, Lee J, Kim T, Inn KS, Kim NJ.
    Bioorg Med Chem Lett; 2015 Sep 01; 25(17):3694-8. PubMed ID: 26115577
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening.
    Cheeseright TJ, Holm M, Lehmann F, Luik S, Göttert M, Melville JL, Laufer S.
    J Med Chem; 2009 Jul 23; 52(14):4200-9. PubMed ID: 19489590
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors.
    Bolós J.
    Mini Rev Med Chem; 2005 Sep 23; 5(9):857-68. PubMed ID: 16178727
    [Abstract] [Full Text] [Related]

  • 18. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM, Sun C, Abad-Zapatero C, Goedken ER, Gum RJ, Borhani DW, Argiriadi M, Groebe DR, Jia Y, Clampit JE, Haasch DL, Smith HT, Wang S, Song D, Coen ML, Cloutier TE, Tang H, Cheng X, Quinn C, Liu B, Xin Z, Liu G, Fry EH, Stoll V, Ng TI, Banach D, Marcotte D, Burns DJ, Calderwood DJ, Hajduk PJ.
    ACS Chem Biol; 2011 Mar 18; 6(3):234-44. PubMed ID: 21090814
    [Abstract] [Full Text] [Related]

  • 19. Successful structure-based design of recent p38 MAP kinase inhibitors.
    Karcher SC, Laufer SA.
    Curr Top Med Chem; 2009 Mar 18; 9(7):655-76. PubMed ID: 19689372
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and characterization of N', N"-diaryl ureas as p38 kinase inhibitors.
    Kulkarni RG, Laufer S, Mangannavar C, Garlapati A.
    Med Chem; 2013 Mar 18; 9(2):213-21. PubMed ID: 22946566
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.